Table 1 The number of patients and direct medical costs of bladder cancer by stage in Iran in 2018
From: Direct and indirect medical costs of bladder cancer in Iran
Stage | Number of patients | Average cost per patient ($) | Total cost ($) | Percentage of total cost | |||||
|---|---|---|---|---|---|---|---|---|---|
Year of diagnosis | Sum (percentage of total) | Year of diagnosis | Year of diagnosis | Sum | |||||
2014–17 | 2018 | 2014–17 | 2018 | 2014–17 | 2018 | ||||
Low grade (Ta) | 7798 | 2368 | 10,166 (46.62) | 274 | 1362 | 2,134,122 | 3,224,377 | 5,358,499 | 18.7 |
High grade (Ta) | 1452 | 592 | 2044 (9.37) | 1087 | 3553 | 1,578,306 | 2,103,355 | 3,681,661 | 12.8 |
T1 | 1850 | 846 | 2696 (12.36) | 1128 | 3552 | 2,086,941 | 3,004,793 | 5,091,733 | 17.8 |
Carcinoma in situ | 925 | 423 | 1348 (6.18) | 1173 | 2473 | 1,084,856 | 1,045,946 | 2,130,802 | 7.4 |
T2–T3 | 2701 | 1087 | 3788 (17.37) | 1145 | 4978 | 3,093,819 | 5,411,229 | 8,505,048 | 29.7 |
Metastatic | 1040 | 725 | 1765 (8.09) | 1335 | 3450 | 1,388,710 | 2,501,455 | 3,890,166 | 13.6 |
Sum | 15,766 | 6041 | 21,807 (100) | 721 | 2862 | 11,366,754 | 17,291,156 | 28,657,910 | 100 |